# Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)

> **NCT02151539** · — · TERMINATED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 19 (actual)

## Conditions studied

- Graft Versus Host Disease

## Interventions

- **OTHER:** medical chart review
- **OTHER:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT02151539
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-08-29
- **Primary completion:** 2018-10-11
- **Final completion:** 2018-10-11
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2019-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02151539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02151539, "Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT02151539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*